Medable CEO Michelle Longmire and Dr. David Fajgenbaum, co-founder of EveryCure, join Pharmaceutical Executive podcast to discuss:
- How Fajgenbaum found a way to save his own life through drug repurposing
- Longmire and Fajgenbaum’s work together and new partnership to repurpose drugs to treat rare diseases
- How to identify which drugs have the potential to treat other therapeutic areas
- Navigating the regulatory landscape
- The future of drug repurposing
Together in their new partnership, Longmire and Fajgenbaum to treat rare diseases by repurposing drugs that are already on the market and finding other therapeutic areas where these drugs can have an impact.
Listen in here: